Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care
Philips (NYSE: PHG) has expanded its partnership with Ibex Medical Analytics and released a new version of Philips IntelliSite Pathology Solution (PIPS) to accelerate AI-enabled digital pathology adoption. The enhanced collaboration aims to address the global pathologist shortage and increasing cancer cases.
The integration of Ibex's AI and Philips' digital pathology solution has demonstrated up to 37% improvement in reporting efficiency. The partnership enables pathology laboratories to utilize PIPS with Ibex's AI-powered tools for prostate, breast, and gastric cancer diagnostics.
The new PIPS 6.0 release includes improved workflows, full scan mode for pathology SG scanner, contextual AI launch, and counter marker tools. The system offers AI-focused worklists showing processing status at case level, and automatic slide sharing with Ibex AI applications. Through collaboration with Amazon Web Services, Philips will provide cloud archival services for efficient data management.
Philips (NYSE: PHG) ha ampliato la sua partnership con Ibex Medical Analytics e ha rilasciato una nuova versione della Philips IntelliSite Pathology Solution (PIPS) per accelerare l'adozione della patologia digitale abilitata dall'IA. Questa collaborazione potenziata mira a affrontare la carenza globale di patologi e l'aumento dei casi di cancro.
L'integrazione dell'IA di Ibex e della soluzione di patologia digitale di Philips ha dimostrato un miglioramento del 37% nell'efficienza dei report. La partnership consente ai laboratori di patologia di utilizzare PIPS con gli strumenti potenziati dall'IA di Ibex per la diagnosi di cancro alla prostata, al seno e gastrico.
Il nuovo rilascio di PIPS 6.0 include flussi di lavoro migliorati, modalità di scansione completa per lo scanner di patologia SG, avvio dell'IA contestuale e strumenti per i marcatori di conteggio. Il sistema offre liste di lavoro focalizzate sull'IA che mostrano lo stato di elaborazione a livello di caso e condivisione automatica delle fette con le applicazioni IA di Ibex. Attraverso la collaborazione con Amazon Web Services, Philips fornirà servizi di archiviazione cloud per una gestione efficiente dei dati.
Philips (NYSE: PHG) ha ampliado su asociación con Ibex Medical Analytics y ha lanzado una nueva versión de la Philips IntelliSite Pathology Solution (PIPS) para acelerar la adopción de la patología digital habilitada por IA. La colaboración mejorada tiene como objetivo abordar la escasez global de patólogos y el aumento de casos de cáncer.
La integración de la IA de Ibex y la solución de patología digital de Philips ha demostrado hasta un 37% de mejora en la eficiencia de los informes. La asociación permite a los laboratorios de patología utilizar PIPS con las herramientas impulsadas por IA de Ibex para diagnósticos de cáncer de próstata, mama y gástrico.
El nuevo lanzamiento de PIPS 6.0 incluye flujos de trabajo mejorados, modo de escaneo completo para el escáner de patología SG, lanzamiento de IA contextual y herramientas de marcadores de conteo. El sistema ofrece listas de trabajo centradas en IA que muestran el estado de procesamiento a nivel de caso y compartición automática de diapositivas con las aplicaciones de IA de Ibex. A través de la colaboración con Amazon Web Services, Philips proporcionará servicios de archivo en la nube para una gestión eficiente de datos.
필립스 (NYSE: PHG)는 이벡스 메디컬 애널리틱스와의 파트너십을 확대하고 필립스 인텔리사이트 병리 솔루션(PIPS)의 새로운 버전을 출시하여 AI 기반 디지털 병리학의 채택을 가속화했습니다. 향상된 협업은 전 세계 병리학자 부족과 증가하는 암 사례를 해결하는 것을 목표로 합니다.
이벡스의 AI와 필립스의 디지털 병리 솔루션의 통합은 보고 효율성에서 최대 37% 개선을 보여주었습니다. 이 파트너십은 병리학 실험실이 PIPS와 이벡스의 AI 기반 도구를 사용하여 전립선, 유방 및 위암 진단에 활용할 수 있도록 합니다.
새로운 PIPS 6.0 버전은 개선된 작업 흐름, 병리 SG 스캐너의 전체 스캔 모드, 맥락적 AI 시작 및 카운터 마커 도구를 포함합니다. 이 시스템은 사례 수준에서 처리 상태를 보여주는 AI 중심 작업 목록과 이벡스 AI 애플리케이션과의 자동 슬라이드 공유 기능을 제공합니다. 아마존 웹 서비스와의 협력을 통해 필립스는 효율적인 데이터 관리를 위한 클라우드 아카이브 서비스를 제공합니다.
Philips (NYSE: PHG) a élargi son partenariat avec Ibex Medical Analytics et a lancé une nouvelle version de la Philips IntelliSite Pathology Solution (PIPS) pour accélérer l'adoption de la pathologie numérique alimentée par l'IA. Cette collaboration renforcée vise à répondre à la pénurie mondiale de pathologistes et à l'augmentation des cas de cancer.
L'intégration de l'IA d'Ibex et de la solution de pathologie numérique de Philips a montré une amélioration de 37 % de l'efficacité des rapports. Ce partenariat permet aux laboratoires de pathologie d'utiliser PIPS avec les outils alimentés par l'IA d'Ibex pour le diagnostic des cancers de la prostate, du sein et de l'estomac.
La nouvelle version PIPS 6.0 comprend des flux de travail améliorés, un mode de numérisation complet pour le scanner de pathologie SG, un lancement d'IA contextuel et des outils de marqueurs de comptage. Le système propose des listes de travail axées sur l'IA montrant l'état de traitement au niveau des cas, ainsi qu'un partage automatique des lames avec les applications IA d'Ibex. Grâce à la collaboration avec Amazon Web Services, Philips fournira des services d'archivage cloud pour une gestion efficace des données.
Philips (NYSE: PHG) hat seine Partnerschaft mit Ibex Medical Analytics erweitert und eine neue Version der Philips IntelliSite Pathology Solution (PIPS) veröffentlicht, um die Einführung der KI-gestützten digitalen Pathologie zu beschleunigen. Die verbesserte Zusammenarbeit zielt darauf ab, dem globalen Mangel an Pathologen und den steigenden Krebsfällen entgegenzuwirken.
Die Integration von Ibex' KI und Philips' digitaler Pathologielösung hat eine Verbesserung der Berichterstattungseffizienz um bis zu 37% gezeigt. Die Partnerschaft ermöglicht es Pathologielaboren, PIPS mit Ibex' KI-gestützten Werkzeugen für die Diagnostik von Prostata-, Brust- und Magenkrebs zu nutzen.
Die neue Version PIPS 6.0 umfasst verbesserte Arbeitsabläufe, einen Vollscan-Modus für den Pathologie SG-Scanner, kontextuelles KI-Starten und Zählermarker-Tools. Das System bietet KI-fokussierte Arbeitslisten, die den Verarbeitungsstatus auf Fallbasis anzeigen, sowie eine automatische Folienfreigabe mit Ibex KI-Anwendungen. Durch die Zusammenarbeit mit Amazon Web Services wird Philips Cloud-Archivierungsdienste für eine effiziente Datenverwaltung bereitstellen.
- 37% improvement in pathology reporting efficiency and productivity
- Integration with AWS enables scalable cloud archival services
- Enhanced AI capabilities for three major cancer types (prostate, breast, gastric)
- Streamlined workflow automation through PIPS 6.0 release
- AI tools remain Research Use Only (RUO) in the US market
Insights
Philips' expanded partnership with Ibex Medical Analytics represents a strategic enhancement of their digital pathology capabilities at a critical time for the healthcare industry. The integration addresses two significant market pressures: the global shortage of pathologists and increasing cancer diagnosis demands.
The reported 37% productivity gain from their combined solution is particularly significant in the pathology space, where efficiency improvements directly translate to faster diagnoses and increased capacity for labs facing staffing challenges. This quantifiable benefit provides Philips with a compelling value proposition when approaching healthcare systems.
The introduction of PIPS 6.0 with AI capabilities integrated directly into workflow represents an evolution from standalone diagnostic tools toward comprehensive clinical workflow solutions. The AWS cloud archiving partnership is equally notable, as it addresses the massive data storage requirements that have previously hindered digital pathology adoption.
From a competitive standpoint, this integrated approach helps Philips differentiate in the growing digital pathology market against players like Leica Biosystems and Hamamatsu. The testimonials from established labs like Alverno and Medipath provide important validation that could accelerate adoption, especially among institutions hesitant about AI implementation.
For Philips, this development aligns perfectly with their strategic focus on health technology and recurring revenue streams from software and services, rather than just hardware. The integration capabilities suggest potential for additional partner integrations, establishing PIPS as a potential platform play in the diagnostic space.
The expanded Philips-Ibex partnership addresses a critical pain point in pathology with its workflow-centric approach. Rather than simply offering AI as a separate tool, the integration directly into the scanning and case management workflow represents a significant usability advancement that could drive real-world adoption.
The specific workflow enhancements in PIPS 6.0 - including contextual AI launching, AI-focused worklists showing processing status, and automatic slide sharing post-digitization - eliminate several manual steps that typically create friction in digital pathology implementation. These features directly address the resistance factors I've observed in pathology departments attempting digital transformation.
For cancer diagnostics specifically, the workflow improvements for prostate, breast, and gastric cancer represent high-volume areas where efficiency gains have substantial impact. The system's ability to prioritize cases could help ensure urgent diagnoses aren't delayed, addressing a key risk in traditional workflows.
The full scan mode for the SG scanner optimizes the digitization process, while the counter marker tool improves the quantification workflows that pathologists rely on for consistent reporting. These features translate to practical time savings and standardization of reporting.
Most importantly, the cloud archiving capability addresses the long-term storage challenge that has been a significant barrier to adoption for many pathology departments concerned about infrastructure costs and maintenance. This could lower the total cost of ownership, making digital pathology financially viable for more institutions.
March 24, 2025
Interoperable AI-powered digital pathology workflows support confident cancer diagnosis
Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its partnership with Ibex Medical Analytics (Ibex) and a new release of Philips IntelliSite Pathology Solution (PIPS) to further accelerate the adoption of AI-enabled digital pathology to address the pressure pathologists face because of the global shortage of pathologists and the growing number of cancer patients. Following the start of the partnership in 2021, Philips and Ibex can now offer even further interoperability of its solutions, aiming to enhance diagnostic workflows for clinicians and enabling better care for more people.
Enhanced Diagnostic Accuracy and Efficiency
Ibex's AI and Philips’ digital pathology solution have shown to improve reporting efficiency and drive productivity gains of up to
Expanding access and streamlining the use of AI-powered tools in digital pathology will further enhance the efficiency and effectiveness of pathology labs. Enabling AI directly in digital pathology workflows empowers clinicians to generate objective, reproducible results, increasing diagnostic confidence and enabling the productivity improvements needed to address the growing demand for pathology-based diagnostics.
“Pathology provides key information for a precise diagnosis. The Philips and Ibex solutions are especially beneficial to the diagnosis of cancer cases because they aid our pathologists in making an accurate and quick diagnosis,” said Sam Terese, President & CEO of Alverno Laboratories. “These integrated pathology solutions help us provide the highest possible quality result that any lab can deliver, getting answers back to our clinicians quickly and saving patients sleepless nights, even on complex cases.”
By further integrating Ibex's AI with PIPS, the solutions can offer optimized workflows, including help with case prioritization, AI-powered cancer detection and reporting, providing easier integration of productivity enhancing tools for more confident diagnosis, supporting better patient care.
Improved features and Cloud Archiving
Philips is also introducing Philips IntelliSite Pathology 6.0, including several new features and AI capabilities [2] into the system. By providing advanced analysis and insights based on the context of the scanned images, pathology teams can access a seamless, AI-powered [2] clinical workflow solution, from case management through to diagnosis and reporting.
“The enhanced interoperability between Philips and Ibex platforms, which are now more seamlessly integrated into our diagnostic workflows, will accelerate the adoption of augmented pathology tools in which we strongly believe,” said Stéphane Rossat, Innovation & Scientific Director and Project Management at Medipath. “PIPS 6.0 promises to facilitate adoption by our physicians, thanks to its streamlined navigation and optimized workflows.
We are eager to contribute to the evolution toward true digital "cockpits," which will become the reference interface for our pathologists.”
PIPS 6.0 features improved workflows and enhancements including full scan mode for the pathology SG scanner and contextual launch of AI [2] and counter marker tool in the image management system, as well as improved scalability. AI focused worklists show AI processing status at a case level and slides can automatically be shared with Ibex AI applications, for processing right after digitization. This new version of the Philips digital pathology solution offers optimized workflows, designed to enhance the efficiency and improved patient care.
Based on Philips’ collaboration with Amazon Web Services, offerings for cloud archival services will allow pathology labs to efficiently and securely store, manage, and analyze growing volumes of digital pathology data. For further information on Philips’ full digital pathology portfolio, please visit here and which will also be showcased at the US & Canadian Academy of Pathology (USCAP) Annual Conference in Boston March 24-27, 2025.
[1] Information provided by Ibex AI: Raoux, et al. Modern Pathology (2021) 34 (suppl 2): 598-599. Ibex AI is RUO in the US.
[2] PIPS enables iSyntax files and with the Software Development Kit (SDK) third-party companies can use this for AI capabilities. PIPS 6.0 contextual launch of Ibex AI is RUO in the US.
For further information, please contact:
Anna Hogrebe
Philips Global External Relations
Tel.: +1 416 270 6757
E-mail: anna.hogrebe@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
- Review of results in PIPS 6 with Ibex AI launched
- PIPS 6.0 with Ibex AI
- Pathologist and PIPS 6.0 with Ibex AI
FAQ
What improvements in efficiency does the Philips-Ibex AI pathology partnership deliver for PHG?
What new features are included in Philips' PIPS 6.0 pathology solution?
Which types of cancer can Ibex's AI tools diagnose through the PHG partnership?
How does the PHG-Ibex partnership address the pathologist shortage?
